Sponsored by Dell

International Business Times Logo

Pfizer profit beats, reassures on long-term view

Pfizer Inc posted higher-than-expected quarterly results and stood by its longer-term profit view, allaying investor concern over looming generic drug competition and lifting its shares 5 percent.